3-Beta-D-ribofuranosylthiazolo[4,5-d]py rimidine nucleosides and uses thereof

Details for Australian Patent Application No. 2002365412 (hide)

Owner Anadys Pharmaceuticals, Inc.

Inventors Rueden, Erik J; Webber, Stephen E; Averett, Devron R; Lennox, Joseph R

Agent Griffith Hack

Pub. Number AU-B-2002365412

PCT Number PCT/US02/38001

PCT Pub. Number WO2003/045968

Priority 60/333,460 27.11.01 US

Filing date 27 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 9 October 2008

International Classifications

C07H 19/24 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

A61K 31/7052 (2006.01)

A61K 31/708 (2006.01)

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/333,460 27.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002365412

7 August 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read 3-Beta-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof 2003

9 October 2008 Application Accepted

  Published as AU-B-2002365412

5 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002365413-VALVE ELEMENTS FOR PRESSURIZED CONTAINERS AND ACTUATING ELEMENTS THEREFOR

2002365411-Composite bicycle rim with seamless braking surface